Journal of the European Academy of Dermatology and Venereology, 2024-08, Vol.38 (8), p.e666-e670
- Cañueto, J.
- Muñoz‐Couselo, E.
- Cardona‐Machado, C.
- Becerril‐Andrés, S.
- Martín‐Vallejo, J.
- Serra‐Guillén, C.
- Soria, A.
- Serrano‐Domingo, J. J.
- Ortiz‐Velez, C.
- Lostes, J.
- García‐Castaño, A.
- Puig, S.
- Fernández de Misa, R.
- Medina, J.
- Aguado, C.
- Ayala de Miguel, P.
- Navarro‐Navarro, I.
- Masferrer, E.
- Delgado, M.
- Bellido‐Hernández, L.
- Sanmartin, O.
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Cañueto, J.
- Muñoz‐Couselo, E.
- Cardona‐Machado, C.
- Becerril‐Andrés, S.
- Martín‐Vallejo, J.
- Serra‐Guillén, C.
- Soria, A.
- Serrano‐Domingo, J. J.
- Ortiz‐Velez, C.
- Lostes, J.
- García‐Castaño, A.
- Puig, S.
- Fernández de Misa, R.
- Medina, J.
- Aguado, C.
- Ayala de Miguel, P.
- Navarro‐Navarro, I.
- Masferrer, E.
- Delgado, M.
- Bellido‐Hernández, L.
- Sanmartin, O.
- Titel
- Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real‐world retrospective study from Spain and systematic review of the published data
- Ist Teil von
- Journal of the European Academy of Dermatology and Venereology, 2024-08, Vol.38 (8), p.e666-e670
- Ort / Verlag
- England
- Erscheinungsjahr
- 2024
- Quelle
- Wiley Online Library Journals【Remote access available】
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0926-9959, 1468-3083eISSN: 1468-3083DOI: 10.1111/jdv.19821Titel-ID: cdi_proquest_miscellaneous_2922449803
- Format
- –
- Schlagworte
- Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized - adverse effects, Antibodies, Monoclonal, Humanized - therapeutic use, Antineoplastic Agents, Immunological - adverse effects, Antineoplastic Agents, Immunological - therapeutic use, Carcinoma, Squamous Cell - drug therapy, Female, Humans, Male, Middle Aged, Retrospective Studies, Skin Neoplasms - drug therapy, Spain, Treatment Outcome